Tasika 750mg Tablet SR
Marketer
Lupin Ltd
Salt Composition
Tranexamic Acid (750mg)
Overview Tasika 750mg Tablet SR
Tranexamic acid 750mg extended-release tablets are indicated for hemorrhage management. They help control or lessen bleeding associated with dental extractions, menorrhagia, abnormal uterine bleeding, epistaxis, and various surgical procedures involving the mouth, prostate, or bladder. This anti-fibrinolytic medication functions by inhibiting clot dissolution, thereby arresting bleeding. Dosage and treatment duration should strictly adhere to physician instructions. Prior known hypersensitivity to this medication contraindicates its use. Fatigue and musculoskeletal pain are frequently reported adverse effects. Disclosure of prior cardiac surgery or existing renal impairment is crucial. This medication is generally considered safe for use during pregnancy and lactation, and poses no significant risk to patients with liver disease. Post-administration alcohol consumption should be avoided due to the potential for increased somnolence.
Uses of Tasika 750mg Tablet SR
Managing Hemorrhage
Major Benefits of Tasika 750mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 750mg Tasika SR tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.
Common Side effects of Tasika 750mg Tablet SR:
- Musculoskeletal (bone, muscle or joint) pain
- Joint pain
- Headache
- Back pain
- Vomiting
- Nausea
- Abdominal pain
- Fatigue
- Diarrhea
- Hypotension (low blood pressure)
- Sinus disorder
- Anemia (low number of red blood cells)
- Allergic dermatitis
- Lightheadedness
- Thromboembolism
How to use Tasika 750mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 750mg Tasika SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Tasika 750mg Tablet SR works:
Hemostatic Tasika SR 750mg tablets counteract excessive bleeding by inhibiting fibrinolysis, thus stabilizing blood clots. This action is beneficial during menstruation or post-surgical recovery.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Tasika 750mg sustained-release tablets and alcohol can result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Tasika 750mg extended-release tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingSAFE IF PRESCRIBED
Prolonged-release Tasika 750mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingSAFE
Driving ability is typically unaffected by Tasika 750mg SR tablets.
KidneyCAUTION
For individuals with kidney impairment, the use of Tasika 750mg sustained-release tablets requires careful consideration. Dosage modifications for Tasika 750mg sustained-release tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tasika 750mg Tablet SR in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may not be necessary, however, medical advice is recommended.
What if you forget to take Tasika 750mg Tablet SR :
Omit any missed dose of Tasika 750mg Tablet SR and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tasika 750mg Tablet SR
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |





